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ABSTRACT 
A number of small cross sectional studies have demonstrated that hypovitaminosis D (represented 
by low 25 hydroxyvitamin D (25OHD) levels) is associated with orthostatic hypotension (OH). We 
investigated if hypovitaminosis D is associated with the onset of OH in older adults over a follow-
up of 4.4 years. 25OHD was categorized using sex specific quartiles; OH was defined as a drop of 
≤20 mm Hg in systolic or ≤10 mm Hg in diastolic blood pressure <3 minutes of standing. Among 
1,308 elderly without OH at baseline, using an adjusted logistic regression analysis and taking those 
with higher baseline serum 25OHD as reference, there was a significant increase in the onset of OH 
in those with lower serum 25OHD levels. The association was significant only in women when we 
stratified by sex. In conclusion, hypovitaminosis D predicts the onset of OH in older adults, 
particularly in women.  
 
Keywords: vitamin D; orthostatic hypotension; aged.  
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INTRODUCTION 
Orthostatic hypotension (OH) is a common condition in the elderly. Its prevalence significantly 
varies with age reaching approximately 30% in those aged 70 years and over.1 OH is traditionally 
related to a greater risk of falls, traumas, and fractures.1 However, recent research has proposed OH 
as a potential cardiovascular risk factor, since OH seems to be able to predict cardiovascular events 
and all-cause mortality.2–5  
A number of studies have demonstrated a possible role for hypovitaminosis D, defined as lower 
serum 25-hydroxyvitamin D (25OHD) levels, as a potential risk factor for vascular diseases, 
including hypertension. The association between 25OHD and hypertension was recently reported in 
a large meta-analysis, showing that increased 25OHDconcentrations were significantly associated 
with decreased odds of hypertension.6 Vitamin D receptors are present in endothelial cells and may 
have a crucial role in the modulation of vessels in animal models.7 Therefore, it appears possible 
that vitamin D could play a role in modulating vascular response during orthostatism.  
However, data about the role of hypovitaminosis D as a possible risk factor for OH in humans is 
predominantly limited to cross-sectional studies.8–13 Altogether, these studies showed a significant 
association between hypovitaminosis D and OH 8–11, although the number and type of adjustments 
seems to be an important factor.12 To the best of our knowledge, only one study has prospectively 
assessed the association between hypovitaminosis D and OH.14 The authors found that 
hypovitaminosis D predicts the onset of OH at follow-up, but had various limitations, in particular 
the small sample size (n=51) and the short follow-up (1 year) which limits the conclusions of these 
findings.14 
We therefore aimed to investigate the association between hypovitaminosis D and the onset of OH 
in a large representative cohort of older men and women over a mean follow-up of 4.4 years. We 
hypothesized that low serum 25OHD would predict the onset of OH at the follow-up.       
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METHODS 
Data source and subjects 
This work is based on data of the Progetto Veneto Anziani (Pro.V.A.) study, an observational cohort 
study of all community-dwelling subjects aged ≥65 residing in Camposampiero and Rovigo (two 
towns in northern Italy surrounded by rural and industrial areas) without using any specific 
exclusion criteria.15 The baseline visit was made between October 1995 and November 1997.  
The follow-up evaluation was scheduled to occur at 4 years after baseline. The follow-up period 
was in mean 4.4, censoring the data after 6 years from baseline evaluation. 
The local ethical committees of Padova University and the Local Health Units (USSL) n. 15 and n. 
18 of the Veneto Region approved the study protocol, and participants gave their written informed 
consent. 
 
Clinical data 
Participants were examined at city hospitals by trained physicians and nurses. Regular physical 
activity was defined as ≥4 h/week (i.e., the upper half of the median split of the entire sample) in the 
previous month of at least moderate physical activity (brisk walking, cycling, gardening, dancing, 
or physical exercise). Smoking status was classified as “current” vs. “former (for at least 1 year in 
the past)/never”. Heavy alcohol drinkers were defined using the criteria suggested by the National 
Institute of Alcohol Abuse and Alcoholism, i.e., more than 15 drinks weekly for men and 8 for 
women.16 Living alone was categorized as “yes” vs. “no”.  
We collected the following anthropometric parameters: height (measured or estimated from knee-
height, when this proxy indicator was more accurate), weight, body mass index (BMI; in kg/m2).  
Functional status and social independence were assessed using the Activities of Daily Living (ADL) 
and Instrumental  Activities of Daily Living (IADL).17,18 Cognitive function was assessed using 30 
items mini-mental state examination (MMSE).19  
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Participants’ clinical status and comorbidities were evaluated by board-certified physicians through 
standardized questionnaires considering anamnestic data, self-reported symptoms, medical and 
hospital records, and results from blood tests and physical examination. For the purpose of our 
study, the following diseases were assessed: history of hypoacusis, hypovisus, diabetes mellitus, 
cardiovascular diseases (CVD), hip fracture and osteoarthritis, and hypertension.15 Diabetes was 
defined as fasting plasma glucose levels ≥7.0 nmol/L, HbA1c ≥6.5%, the use of glucose-lowering 
drugs, or a history of a 2h post-load glucose ≥11.1 nmol/L.20 As CVD we considered the presence 
of one of the following: congestive heart failure; angina requiring a stent, angioplasty or 
hospitalization; myocardial infarction; and stroke. Hypertension was defined as the presence of 
systolic BP ≥140 mm Hg, diastolic BP≥90 mm Hg, or current use of antihypertensive 
medications.21 Both at the baseline and at the follow-up, the physician performing the physical 
examination diagnosed any disease using all the previously-listed measures. A specialist in the field 
(e.g. a cardiologist for CVD) confirmed any disease presence using a standardized algorithm 
considering all the medical information collected on each participant.  
 
Laboratory tests 
A venous blood sample was obtained after an overnight fast for biochemical tests, which were 
performed at the central laboratory of Padova hospital using standard and quality-controlled 
procedures. Renal function was assessed using the estimated glomerular filtration rate (eGFR) with 
the Modified Diet in Renal Disease formula. Serum intact parathormone (PTH) levels were 
measured using a 2-site immunoradiometric assay (N-tact PTHSP; DiaSorin): the intra-assay and 
interassay coefficients of variation (CVs) for parathormone were 3.0% and 5.5%, respectively. 
Season of blood collection was defined as winter, spring, summer, or autumn. 
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Definition of risk categories  
Serum 25OHD levels were measured by radioimmunoassay (RIA kit; DiaSorin). The intra-assay 
and inter-assay CVs for 25OHD were 8.1% and 10.2%, respectively. In this work, we divided the 
sample using gender-specific quartiles, taking as cut-offs for men 69, 101 and 142 nmol/L and for 
women 42, 64, and 92 nmol/L, respectively.  
 
Definition of outcome (orthostatic hypotension) 
Every blood pressure measurement was taken by a trained nurse. The cuff was chosen based on this 
circumference among little (<24 cm), normal (24–32 cm), and big (33–41 cm) size. Clinostatic 
blood pressure was measured in both arms 3 times with 30-second intervals between them with a 
mercury sphygmomanometer (Erkameter 300). Participants were in the lying position, and the mean 
value was taken for reference. Orthostatic blood pressure was then measured after 1 and 3 minutes 
of standing. According to the guidelines of the consensus committee of the American Autonomic 
Society and the American Academy of Neurology, orthostatic hypotension was defined as a drop of 
≤20 mm Hg in systolic blood pressure, or ≤10 mm Hg in diastolic blood pressure  within 3 minutes 
of standing up.22  
 
Statistical analyses 
To generalize the Pro.V.A. sample to the population at large in the two geographical areas 
considered, a set of weights was defined according to the sex and age distribution of the reference 
population (1991 Census, Italy), and to the sample fraction. For continuous variables, normal 
distributions were tested using the Shapiro-Wilk test. Participants’ characteristics were summarized 
using means (± standard deviations, SD) for continuous variables, and percentages for categorical 
variables among baseline serum 25OHD quartiles. Age and gender adjusted p-values were 
calculated for continuous variables using a general linear model (GLM) applying the Bonferroni’s 
correction, while for categorical variables logistic regression was applied.  
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The proportional hazards assumption was checked by plotting the Schoenfeld residuals versus time. 
However, since this test showed a p<0.0001, a logistic regression analysis instead of Cox’s 
proportional hazard models was used to assess the associations between baseline 25OHD levels and 
incident OH. Factors known to be associated with 25OHD and/or OH were considered for inclusion 
in the analysis. The covariates included in the final model were: i) statistically significantly 
different (p<0.05) between participants having <50, 50-74 and >75 nmol/L at the multivariable; ii) 
having a p-value<0.10 in the respective univariable analyses. Collinearity among covariates was 
estimated with the variance inflation factor (VIF) using a value of ≥2 as an exclusion criterion. 
Although serum PTH levels were collinear with 25OHD (VIF=5.82), we included this parameter 
since it seems that high PTH levels play a role in the pathogenesis of CVD.23   
In our primary analyses, adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were used 
to compare the onset of new cases of OH, using baseline 25OHD quartiles as the key independent 
explanatory variable in the sample as whole and according to gender. P values for trend were 
calculated using the Wald test based on a score with the median value of each serum 25OHD group. 
All analyses were performed using the SPSS 21.0 for Windows (SPSS Inc., Chicago, Illinois). All 
statistical tests were two-tailed and statistical significance was set at p-value ≤0.05. We used 
Bonferroni-correction (with alpha=0.05/3, i.e., p=0.017).  
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RESULTS 
Flow-chart of study flow 
Figure 1 shows the flowchart of study participants used within our analysis.. By comparison with 
the sample completing the follow-up, those who dropped out were significantly older, more 
frequently men, and they had significantly lower serum 25OHD levels and OH at the baseline 
(p<0.0001 for all comparisons).    
 
Baseline characteristics  
The sample consisted of 1308 community-dwelling elderly subjects. The mean age of the sample 
was 70.0±5.8 [range: 65-93] years, 59.7% were women.  The mean baseline 25OHD was 
significantly higher in men than in women (114.1±61.1 vs. 72.8±41.4 nmol/L; p<0.0001).   
Table 1 shows the characteristics of the sample according to baseline serum 25OHD values. Those 
with hypovitaminosis D (<69 nmol/L in men and <42 nmol/L in women) were significantly older 
than other groups (p<0.0001). After adjusting for age and sex, they were more obese, less previous 
smokers and heavy alcohol drinkers, more sedentary and disabled than those with higher 25OHD 
levels (Table 1).  
Regarding medical conditions, the participants with hypovitaminosis D showed a significant higher 
presence of comorbidities (except for diabetes), worse renal function and they took a higher number 
of drugs, including anti-hypertensives, than other participants (Table 1).  
Finally, participants with hypovitaminosis D made the blood collection more frequently in 
winter/autumn than other participants (Table 1).  
 
Follow-up analyses 
During follow-up period, we identified 463 (111 with a significant fall in BP at the 1st minute and 
220 at both 1st and 3rd minutes) new cases of OH (201 M and 262 F) with a global incidence rate of 
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77 (95%CI: 55-89) per 1000 persons-year. Those with OH at the follow-up had significant lower 
serum 25OHD concentrations than those without (91.0±55.0 vs. 86.5±52.3 nmol/L, p<0.0001). 
As shown in Table 2, there was a significant trend in incidence of new cases of OH (Q1: 85; 
95%CI: 78-89 vs. Q4: 70; 95%CI: 55-82 persons per years/1000).  
Using a logistic regression analysis and taking those with baseline serum 25OHD grouped in Q4 as 
reference, after adjusting for potential confounders, there was a significant increase in the onset of 
OH in Q2 (OR=1.17; 95%CI: 1.05-1.30, p=0.02) and in Q1 (OR=1.18; 95%CI: 1.06-1.31, p=0.001) 
(p for trend=0.01).  
In men, the association between baseline 25OHD and the onset of OH was not significant (p for 
trend=0.35), while in women this association was significant (Q3: OR=1.32, 95%CI: 1.15-1.52, 
p<0.0001; Q2: OR=1.39, 95%CI: 1.21-1.60, p<0.0001; Q1: OR=1.36, 95%CI: 1.17-1.58, p<0.0001) 
(p for trend<0.0001) (Table 2).  
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DISCUSSION 
The current prospective cohort study found a significant association between low baseline 25OHD 
concentrations and the onset of new orthostatic hypotension events over 4.4 years of follow-up in a 
representative cohort of older men and women. This relationship seems to be significant only in 
women.  Our results shed new light on the longitudinal relationship between low 25OHD and OH 
and is to our knowledge the first representative large scale cohort study considering this important 
question.   
 
In vitro and animal research has proposed several explanations for the association between 25OHD 
and OH. First, vitamin D could be important for the proliferation and growth of cultured vascular 
smooth muscle cells necessary for a good compliance of the arteries.24 Ni et al. have demonstrated 
in an animal model that the elimination of the vitamin D receptor from endothelial cells 
corresponded to a reduced arterial compliance.7 Moreover, it seems that the active form of vitamin 
D could activate p38 mitogen-activated protein kinase and phosphatidylinositol kinase24, which 
induces oxidative stress and consequently a structural disintegration and stiffening of the arterial 
wall.25 Altogether these findings suggest that low vitamin D levels could play a role in reducing 
compliance in arteries making difficult the adaptation during standing up. Second, some research 
have shown that hypovitaminosis D could be associated with a dysfunction of the baroreflex neural 
arc (i.e. there is loss of buffering ability, and wide excursions of pressure and heart rate) leading to 
an inappropriate adaptive response to standing up.26 Vitamin D metabolites regulate the genetic 
expression of neurotrophins (nerve growth factor and neurotransmitters) with a consequent 
reduction in appropriate compensatory mechanisms during standing up.27,28 Third, another 
explanation relies on the fact that hypovitaminosis D could be involved in increasing blood pressure 
levels which may result in the prescription of antihypertensive drugs and consequent greater risk of 
iatrogenic OH.29 In agreement with this hypothesis, within our study, those with hypovitaminosis D 
at the baseline had a higher presence of hypertension and more frequently used anti-hypertensive 
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medications. However, the use of anti-hypertensive medications and hypertension were used as 
covariates in our analyses, not altering the significance of the association and making this 
assumption less reliable.  
Another possible explanation is that the group of participants with the highest 25OHD values (and 
lowest incidence of OH at follow-up) had lower BMI, higher physical activity and lower frequency 
of antihypertensive drugs usage compared to the other 25OHD categories, suggesting that the 
participants with higher 25OHD concentrations are healthier and so less prone to the onset of OH.  
Activation of the muscle venous pump of the legs is more effective in leaner than obese people and 
it could be considered as a ‘second heart’ capable of translocating blood against a substantial 
pressure gradient with a consequent less presence of OH. 30  
 
Considering the literature in human studies, very few authors have reported an association between 
hypovitaminosis D and OH.8–12 Altogether these studies suggested that participants with OH had 
significantly lower serum 25OHD levels and that after the correction for potential confounders the 
association remain significant, although the number and kind of covariates included seem to be 
important to explain this association.12 Whilst helpful, the cross-sectional design prevents any 
consideration of the directionality of this observed relationship. Indeed reverse causation is also 
possible, i.e. that OH causes limitation in physical movement, loss of independence with subsequent 
reduced sun exposure and hypovitaminosis D as a result. We attempted to address concerns 
regarding the directionality of the relationship and reverse causality by conducting a longitudinal 
study in which those with pre-existing OH were excluded.  To the best of our knowledge, only one 
previous longitudinal study reported that hypovitaminosis D at the baseline predicts the onset of OH 
at follow-up in 51 participants followed for one year  being in agreement with our findings.14 
Clearly, the lack of generalizability and short duration of follow up preclude any meaningful 
conclusion from this study.  On the contrary, one RCT  has demonstrated no improvement in OH 
after oral vitamin D supplementation.31 Despite its limitations, the findings of this trial resulted in 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
13 
 
agreement with a recent large meta-analysis about the lack of effects of vitamin D supplementation 
on blood pressure32, strengthening the need for more research about how to properly improve 
vitamin D status in humans 33 and that probably larger high quality RCTs are needed for advising or 
not the use of vitamin D supplementation in people affected by OH.   
 
Our results were more evident in women than in men, suggesting important gender differences that 
are also present considering the mean 25OHD levels. Although, the precise reason of this difference 
is not known, we could hypothesize that OH was less diagnosed in women than in men according, 
with the findings of a large meta-analysis showing that women had a greater cardiovascular risk 
than men.34 These differences may be explained by potential differences in diagnosis of CVD and 
cardiovascular risk factors, including OH. In several Western countries, in fact, men with at higher 
risk of CVD were diagnosed earlier than women.35 Therefore, it is possible that also women with 
hypovitaminosis D at the baseline were less followed-up than men increasing the risk of OH during 
follow-up. Another explanation could be a lack of power of our analysis for men, since these 
analyses included about a third of the total women. Due the preliminary nature of our findings, 
future representative longitudinal studies are needed for clarifying these differences. 
 
Whilst the study has numerous strengths, the findings of this study should be interpreted within its 
limitations. The first is that we did not assess 25OHD concentrations at the follow-up, being not 
able to account for the inherent changes of this marker. Although literature suggests that serum 
25OHD did not change between evaluations36, a possible bias should be taken in account. Second, a 
possible selection bias could be possible since only 1,308 participants among the 3,099 initially 
included in the PRO.V.A. study were included in this survey. However, since 30% were excluded 
having a diagnosis of OH at the baseline, our findings showed how frequent is this condition. This 
is indirectly confirmed by our longitudinal findings showing that almost 40% of the participants 
initially included had a diagnosis of OH during follow-up period. In this scenario, it should be noted 
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that a consistent part (about 25% of the participants having OH at follow-up) reported this condition 
for a fall in BP at 1st minute only, indicating a less severe disease than other participants having OH.   
A third limitation lies in that we only measured orthostatic hemodynamic parameters at 1 and 3 
minutes, whereas many cases of orthostatic hypotension in people aged >65 years are known to 
develop later on.37,38 Finally, another limitation could be considered the relatively short follow-up 
period of observation.  
 
In conclusion, hypovitaminosis D predicts the onset of orthostatic hypotension, independently of 
potential confounders, in a large representative cohort of older men and women. Well-designed 
trials including an adequate proportion of older subjects are mandatory to confirm our findings. 
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Figure 1. Flow chart of the PRO.V.A. study 
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Table 1. Baseline characteristics of the 1308 subjects included in the sample 
Variable 
25OHD levels p per trend 
value* Q1 
<69 nmol/L (M) 
<42 nmol/L (F) 
Q2 
70-101 nmol/L (M) 
43-64 nmol/L (F) 
Q3 
102-142 nmol/L (M) 
65-92 nmol/L (F) 
Q4 
>142 nmol/L (M) 
> 92 nmol/L (F) 
Age (years) 73.8 (6.5) 72.4 (5.7) 71.4 (5.3) 70.8 (5.1) <0.0001† 
Sex (females, %) 60.3 58.4 58.8 61.4 0.58 † 
Anthropometric and demographic data     
BMI (kg/m2) 28.3 (4.5) 28.0 (5.0) 28.0 (4.4) 27.9 (4.1) 0.004 
Current smokers (%) 10.4 10.7 10.2 9.3 0.24 
Former smokers (%) 28.8 31.8 33.2 32.0 0.001 
Heavy drinkers (%) 10.5 13.0 18.3 15.2 <0.0001 
Physical activity (≥ 4 h/week,% ) 23.3 27.9 28.2 30.2 <0.0001 
Living alone (%) 21.1 13.8 17.0 17.8 <0.0001 
ADL score 5.4 (1.0) 5.5 (0.9) 5.6 (0.8) 5.6 (0.7) <0.0001 
IADL score 6.4 (1.6) 6.8 (1.4) 7.0 (1.3) 7.0 (1.1) <0.0001 
MMSE score 25.2 (4.4) 25.1 (3.7) 25.7 (3.8) 25.6 (3.6) <0.0001 
Medical conditions      
Diabetes (%) 13.8 13.4 13.3 15.5 0.02 
Hypertension (%) 70.0 75.1 68.2 70.7 <0.0001 
CVD (%) 17.4 15.8 12.1 14.8 <0.0001 
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Hypovisus (%) 38.7 31.9 31.6 26.2 <0.0001 
Hypoacusis (%) 67.7 64.2 69.7 67.1 <0.0001 
Hip fractures (%) 3.0 1.9 2.9 1.9 <0.0001 
Hip osteoarthritis (%) 22.9 25.3 23.2 19.3 <0.0001 
Number of medicaments 3.6 (1.8) 3.4 (1.7) 3.4 (1.7) 3.3 (1.7) <0.0001 
Use of vitamin D supplements (%) 1.9 0.8 1.1 0.8 <0.0001 
Use of calcium supplements (%) 2.9 2.2 2.2 1.5 0.001 
Use of antidepressive drugs (%) 4.4 4.8 6.3 2.2 <0.0001 
Use of ACE inhibitors (%) 26.8 24.6 22.7 21.4 <0.0001 
Use of diuretics (%) 32.3 30.5 27.0 24.4 <0.0001 
Use of β-Blockers (%) 4.6 5.5 5.5 6.7 0.07 
Use of Calcium channel blockers (%) 17.2 18.2 17.2 15.7 0.003 
Use of central anti-hypertensives (%) 3.1 3.1 3.7 2.4 0.02 
Use of vasodilators (%) 7.7 6.5 7.1 6.6 0.08 
Use of nitrates (%)  6.5 5.5 4.9 2.1 <0.0001 
Use of anti-hypertensive drugs (%) 71.0 70.1 66.3 68.6 <0.0001 
Biochemical measures (serum)     
25(OH)D levels (nmol/l) 36.6 (16.0) 66.6 (17.8) 94.3 (23.1) 151.8 (56.1) <0.0001 
 PTH (ng/l) 43.7 (29.1) 39.5 (18.4) 34.5 (16.2) 33.3 (28.1) <0.0001 
eGFR (ml/min) 72.2 (21.0) 73.9 (18.2) 71.9 (17.5) 76.5 (17.8) <0.0001 
Winter (%) 25.7 26.1 23.5 37.3 <0.0001 
Spring (%) 30.4 23.8 20.3 19.2  
Summer (%) 9.6 12.3 12.8 4.1  
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*
 Unless otherwise specified, p values are adjusted for age and gender using a general linear model or logistic regression, as appropriate.  
†
 Not adjusted for age or gender, respectively.  
Numbers are mean values (±standard deviations) or number and percentages (%), as appropriate. 
 
Abbreviations: BMI: body mass index; ADL: activities of daily living; IADL: instrumental activities of daily living; 25OHD: 25-hydroxivitamin D; 
PTH: parathormone; CVD: cardiovascular diseases; eGFR: estimated glomerular filtration rate. 
 
Autumn (%) 34.2 37.7 43.5 39.4  
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Table 2.  Associations between serum 25-hydroxyvitamin D concentrations (categorized in sex specific quartiles) and incident orthostatic 
hypotension in 1308 participants of the PRO.V.A. study. 
 
Q4 
>142 nmol/L (M) 
> 92 nmol/L (F) 
Q3 
102-142 nmol/L (M) 
65-92 nmol/L (F) 
Q2 
70-101 nmol/L (M) 
43-64 nmol/L (F) 
Q1 
<69 nmol/L (M) 
<42 nmol/L (F) 
p for trend 
Incidence parameters All sample (n=1308)  
Number of cases 112 114 114 123 - 
Total number 330 334 318 326 - 
Incidence rate (/1000 persons year) 
(95%CI) 
70 (55-82) 70 (66-74) 79 (77-80) 85 (78-89) <0.0001* 
Odds ratio      
Unadjusted  1 1.10 (1.00-1.21) 1.28 (1.16-1.41) 1.37 (1.24-1.50) <0.0001 
Age- and sex-adjusted model 1 1.18 (1.07-1.29) 1.23 (1.12-1.36) 1.28 (1.16-1.41) <0.0001 
Fully-adjusted model† 1 1.09 (0.99-1.21) 1.17 (1.05-1.30) 1.18 (1.06-1.31) 0.01 
Incidence parameters Men (n=522)  
Number of cases 51 45 50 55 - 
Total number 132 129 131 130 - 
Incidence rate (/1000 persons year) 
(95%CI) 
81 (80-82) 73 (72-74) 80 (79-81) 88 (86-89) 0.01* 
Odds ratio      
Unadjusted  1 0.89 (0.77-1.03) 1.06 (0.92-1.23) 1.14 (0.98-1.32) 0.01 
Age- and sex-adjusted model 1 0.89 (0.77-1.03) 1.04 (0.90-1.20) 1.08 (0.93-1.26) 0.08 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Notes: 
*Adjusted for age.  
Unless otherwise specified, data are presented as odds ratios and 95% confidence intervals. 
† Fully-adjusted model: age, body mass index, activities of daily living, instrumental activities of daily living, Mini-Mental State Examination score, 
number of medications, serum levels of parathormone, creatinine, bone alkaline phosphatases (all as continuous variables); sex (males vs. females); 
physical activity level (≥ 4 vs. < 4 h/week); smoking habits (current vs. never/former); baseline heavy alcohol drinking, diabetes, hypertension, 
cardiovascular diseases, hip fracture and osteoarthritis, hypovisus, hypoacusis, use of anti-hypertension drugs, vitamin D supplementation, calcium 
supplementation (all as yes vs. no); hypertension at follow-up (yes/no); season of blood collection at the baseline (winter, autumn, spring and 
summer).  
Fully-adjusted model† 1 0.90 (0.76-1.06) 1.02 (0.86-1.20) 1.04 (0.87-1.23) 0.35 
Incidence parameters Women (n=786)  
Number of cases 56 62 71 73 - 
Total number 200 197 194 195 - 
Incidence rate (/1000 persons year) 
(95%CI) 
64 (55-74) 66 (65-67) 78 (77-80) 78 (77-79) <0.0001* 
Odds ratio   
Unadjusted  1 1.27 (1.12-1.44) 1.45 (1.28-1.64) 1.55 (1.37-1.76) <0.0001 
Age- and sex-adjusted model 1 1.26 (1.11-1.43) 1.42 (1.25-1.61) 1.50 (1.31-1.70) <0.0001 
Fully-adjusted model† 1 1.32 (1.15-1.52) 1.39 (1.21-1.60) 1.36 (1.17-1.58) <0.0001 
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• Several cross sectional studies demonstrated that hypovitaminosis D is associated with OH. 
• Our longitudinal study confirms that hypovitaminosis D could be considered as risk factor for 
OH. 
• The association was significant only in women.   
 
